These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 28159657)
1. Dose optimisation of voriconazole with therapeutic drug monitoring in children: a single-centre experience in China. Liu L; Zhou X; Wu T; Jiang H; Yang S; Zhang Y Int J Antimicrob Agents; 2017 Apr; 49(4):483-487. PubMed ID: 28159657 [TBL] [Abstract][Full Text] [Related]
2. Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre. Boast A; Curtis N; Cranswick N; Gwee A J Antimicrob Chemother; 2016 Jul; 71(7):2031-6. PubMed ID: 27009030 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Voriconazole in Children from a Tertiary Care Center in China. Hu L; Dai TT; Zou L; Li TM; Ding XS; Yin T Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30150475 [TBL] [Abstract][Full Text] [Related]
4. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing. Dolton MJ; Mikus G; Weiss J; Ray JE; McLachlan AJ J Antimicrob Chemother; 2014 Jun; 69(6):1633-41. PubMed ID: 24554646 [TBL] [Abstract][Full Text] [Related]
5. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients. Chayakulkeeree M; Poovipirom N; Siengwattana P; Maneerattanaporn M J Med Assoc Thai; 2015 Mar; 98(3):232-7. PubMed ID: 25920292 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Empiric Voriconazole Dosing and Therapeutic Drug Monitoring in Hospitalized Pediatric Patients. Schweiger JA; Heiden AM; MacBrayne CE J Pediatr Hematol Oncol; 2024 Aug; 46(6):e419-e425. PubMed ID: 38934583 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels. Guinea J; Escribano P; Marcos-Zambrano LJ; Peláez T; Kestler M; Muñoz P; Vena A; López-Fabal F; Bouza E Med Mycol; 2016 May; 54(4):353-60. PubMed ID: 26739190 [TBL] [Abstract][Full Text] [Related]
8. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study. Blanco-Dorado S; Maroñas O; Latorre-Pellicer A; Rodríguez Jato MT; López-Vizcaíno A; Gómez Márquez A; Bardán García B; Belles Medall D; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Otero Espinar F; Blanco Hortas A; Durán Piñeiro G; Zarra Ferro I; Carracedo Á; Lamas MJ; Fernández-Ferreiro A Pharmacotherapy; 2020 Jan; 40(1):17-25. PubMed ID: 31782536 [TBL] [Abstract][Full Text] [Related]
9. An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old. Zembles TN; Thompson NE; Havens PL; Kaufman BA; Huppler AR Pharmacotherapy; 2016 Oct; 36(10):1102-1108. PubMed ID: 27548272 [TBL] [Abstract][Full Text] [Related]
10. Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy. Kadam RS; Van Den Anker JN Clin Pharmacokinet; 2016 Sep; 55(9):1031-43. PubMed ID: 26979736 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child-Pugh class B and C cirrhosis: A multicenter study. Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y Int J Infect Dis; 2018 Jul; 72():49-54. PubMed ID: 29793038 [TBL] [Abstract][Full Text] [Related]
12. Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations. Hicks JK; Gonzalez BE; Zembillas AS; Kusick K; Murthy S; Raja S; Gordon SM; Hanna R Pharmacogenomics; 2016 May; 17(7):663-7. PubMed ID: 27143031 [TBL] [Abstract][Full Text] [Related]
13. Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients. Lempers VJ; Meuwese E; Mavinkurve-Groothuis AM; Henriet S; van der Sluis IM; Hanff LM; Warris A; Koch BCP; Brüggemann RJ Med Mycol; 2019 Nov; 57(8):937-943. PubMed ID: 30759261 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients. Hu L; Huang S; Huang Q; Huang J; Feng Z; He G PLoS One; 2023; 18(9):e0288794. PubMed ID: 37695751 [TBL] [Abstract][Full Text] [Related]
15. Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Hamadeh IS; Klinker KP; Borgert SJ; Richards AI; Li W; Mangal N; Hiemenz JW; Schmidt S; Langaee TY; Peloquin CA; Johnson JA; Cavallari LH Pharmacogenet Genomics; 2017 May; 27(5):190-196. PubMed ID: 28306618 [TBL] [Abstract][Full Text] [Related]
16. Dosing and therapeutic drug monitoring of voriconazole in bottlenose dolphins (Tursiops truncatus). Ferrier K; van Elk CE; Bunskoek PE; van den Broek M Med Mycol; 2017 Feb; 55(2):155-163. PubMed ID: 27703023 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency. Gerin M; Mahlaoui N; Elie C; Lanternier F; Bougnoux ME; Blanche S; Lortholary O; Jullien V Ther Drug Monit; 2011 Aug; 33(4):464-6. PubMed ID: 21743382 [TBL] [Abstract][Full Text] [Related]
18. Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole. Qi F; Zhu L; Li N; Ge T; Xu G; Liao S Int J Antimicrob Agents; 2017 Apr; 49(4):403-409. PubMed ID: 28159656 [TBL] [Abstract][Full Text] [Related]
19. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study. Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of voriconazole and CYP2C19 phenotype for dose optimization in paediatric patients. Hu L; Huang Q; Huang S; Feng Z Eur J Clin Pharmacol; 2023 Sep; 79(9):1271-1278. PubMed ID: 37458772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]